Baseimmune
杏吧原创 Score
44
Startups
2
Founding Rounds
6
Investors
$12.35m
Money raised
Overview
Baseimmune, based in London, leverages advanced AI to revolutionize vaccine development, offering a competitive edge in the biotech sector. Their B2B SaaS model aligns with industry trends favoring digital transformations and efficiencies. Unlike traditional methods, Baseimmune's AI algorithms enable faster and more effective vaccine creation, addressing issues like delayed outbreak responses. Backed by investors such as Hoxton Ventures and Merck Global Health Innovation Fund, Baseimmune is well-positioned for significant growth and impact in healthcare.
- Website:
- Business model: b2b, saas
- Company size: 1 - 11 employees
- Headquarters: London, UK
- Founded: 2019
- Social accounts:
Investors (6)
Cherry Ventures
Climate Tech & Green Tech, Health Tech, FinTech, Crypto & web3, Agritech, ...
Details